Thursday, May 9, 2024
Home 2024 Watch List

2024 Watch List

    Most popular

    Ardelyx (ARDX), Raymond James up Price Target, Citigroup Joins the Party.

    2024 Watch List Editor / Curator -
    Wall Street Cozy's up to Ardelyx After New Guidance. On January 8th, Mike Raab, President and Chief Executive...

    Is David Dodd on to his Next Billion Dollar Payday for Shareholders?

    2024 Watch List Editor / Curator -
    Huge News: Gedeptin® Therapy Demonstrated Safety, Stabilization and Shrinkage of Treated Tumors. GeoVax (GOVX) Completes Patient...

    Adding GeoVax (GOVX) $3.32 to Reverse Stock Split Watch List.

    2024 Watch List Editor / Curator -
    Okay, Here's Our First Name for the Reverse Stock Split, Watch List. We'll Venture to Have 10 Names Added to Watch List...

    Adding Terran Orbital (LLAP) $1.15 to Watch List. Risk Arbitrage Idea.

    2024 Watch List Editor / Curator -
    Lockheed Martin (LMT) Offers $1.00 Per Share to Acquire Terran Orbital. LIVE QUOTE

    Latest article

    We’re in Tampa for the Kentucky Derby.

    2024 Watch List Editor / Curator -
    GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

    Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

    Institutional Analyst Newsletter Editor / Curator -
    DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

    Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

    2024 Watch List Editor / Curator -
    Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.